IPRIPR2020-01053Terminated
Slayback Pharma LLC et al.v.Sumitomo Dainippon Pharma Co., Ltd. et al.
IPR challenge of US 9815827.
Type
IPR
Filed
Jun 5, 2020
Instituted
Dec 9, 2020
Decided
May 31, 2024
Patent
Application
14471919
Inventor
Mitsutaka Nakamura et al
Granted
Nov 14, 2017
01
Timeline
3 milestones
2020-06-05Petition filed
2020-12-09Institution
2024-10-14Terminated
02
Parties & counsel
Petitioner
Slayback Pharma LLC et al.
Counsel
Weinstein, Louiset al
Patent Owner
Sumitomo Dainippon Pharma Co., Ltd. et al.
Counsel
Whelan, Dorothyet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →